Bilateral Meetings
- Wednesday 10:40 h – 13:00 h
- Wednesday 14:00 h – 18:00 h
DescriptionExogenus Therapeutics (Exo-T) is a biotechnology company dedicated to pre-clinical and clinical development of advanced therapies for skin diseases. Exo-T envisage becoming a company of reference for the use of exosomes as a treatment tool for skin lesions, including wound healing. The company is presently developing its first product, Exo-Wound, which is derived from Umbilical Cord Blood for the treatment of chronic wounds, which affect millions of people worldwide.
Organization Type
Company
Areas of Activities
Other
Wound healing animal testing
We are looking for partners to develop experiments in animal models such as wound healing efficacy tests and GLP toxicology.
Cooperation Offered
- Technical co-operation
Wound Care licensing opportunity
We are looking for pharma companies commercializing Wound Care products for future out licensing of our product or technology.
Cooperation Offered
- License agreement
Health - Life Sciences Investment
We are looking for investors for the clinical development phase of our product.
Cooperation Requested
- Investment/Financing
Partners wanted: Biobanks aGMP-compliant production
We are looking for biobanks working with Umbilical Cord Blood for research & development based in Europe or USA. We are also looking for GMP production contractors with experience in cell therapy.
Cooperation Requested
- Manufacturing agreement